PAK4 and pancreatic neoplasm: PAK signalling influences endothelial behaviour and immune functions [13]; however, the specific roles of PAK1 or PAK4 in vascular reprogramming, hypoxia, and the gemcitabine response have not been fully addressed in pancreatic cancer.